MiAlgae Secures £2.5M From Scotland’s National Investment Bank, Plans to More Than Double Workforce by 2028

MiAlgae, a biotech company based in Edinburgh, has secured a £2.5 million investment from Scotland's National Investment Bank to support its commercial-scale production facility in Grangemouth. The company, which grows microalgae on by-products from whisky distilling, plans to more than double its workforce from 60 to around 156 by 2028 as it scales output at the site. The microalgae is processed into Omega-3 powder for aquaculture feed and pet nutrition, serving as a sustainable alternative to fish-derived Omega-3.

The investment from the Scottish National Investment Bank adds to the public funding already received by MiAlgae for its Grangemouth plant. The company was founded in 2016 and continues to receive support from the University of Edinburgh, where the founder studied synthetic biology and biotechnology. MiAlgae's mission is to protect oceans, reduce waste, and create a circular solution by transforming whisky industry by-products into high-value Omega-3 ingredients. The new facility in Grangemouth is expected to significantly scale the company's impact in the coming years and contribute to the regeneration of the area as a sustainable industrial hub.